EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions

Brandon D Ng iD, Conor Whelan, Natalia Alkon, Agata Kurowski, Constanze Jonak, Patrick M Brunner iD

Experimental Dermatology · 2026

DOI: 10.1111/exd.70240 ↗

At a glance

Journal article in Experimental Dermatology, 2026. Written by Brandon D Ng and 5 co-authors. Institution: Department of Dermatology, Icahn School of Medicine, New York, USA. Major MEDLINE topics: Mycosis Fungoides, Dermatitis, Atopic, Skin Neoplasms. Cited 2 times so far (Crossref); 82 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIAMS NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Mycosis fungoides (MF) is the most common type of primary cutaneous T‐cell lymphoma, a disease characterized by malignant T cells that home to the skin. In early stages, clinical presentation is often indistinguishable from benign chronic inflammatory skin diseases such as atopic dermatitis (AD), posing a challenge for proper diagnosis and treatment. Previous studies have established that MF is characterized by the expansion of a single T‐cell clone, whereas benign skin conditions are polyclonal in nature. In this study, we aimed to use single‐cell RNA sequencing data to detect distinct transcriptomic features of early‐stage MF in comparison to AD skin. In early‐stage MF, we observed gene expression differences in cells of both the stroma and the immune system, with keratinocytes exhibiting increased interferon response and proliferation ( STAT1 , ICAM1 , HLA‐DRA , GJB2 ), while fibroblasts displayed tumour‐associated programs ( CXCL2 , TNFAIP6 , CEBPD ). Myeloid cells exhibited expression of immunomodulatory genes ( RUNX3 , DDIT4 , IL4I1 ), and malignant T‐cells expressed exhaustion‐associated markers ( CXCL13 , SOCS3 , F2R , ETV1 ), as opposed to AD and healthy control samples. Thus, our results provide a novel insight into the immune‐stroma crosstalk in the tissue microenvironment of early‐stage MF vs. AD skin lesions.

Subjects

MeSH terms (MEDLINE)

Mycosis FungoidesDermatitis, AtopicSkin NeoplasmsHumansSingle-Cell Gene Expression AnalysisKeratinocytesDiagnosis, DifferentialTranscriptomeSkin

Author keywords

CTCLatopic dermatitismycosis fungoidesscRNA‐seq

Authors and institutions

  • Department of Dermatology, Icahn School of Medicine, New York, USA.
  • Department of Dermatology, Medical University of Vienna, Vienna, Austria.

ORCID profiles: Brandon D Ng, Patrick M Brunner

Funding

  • NIAMS NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • Icahn School of Medicine at Mount Sinai
  • National Center for Advancing Translational Sciences
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institutes of Health

Cite

APA

Ng, B. D., Whelan, C., Alkon, N., Kurowski, A., Jonak, C., & Brunner, P. M. (2026). Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions. Experimental Dermatology. https://doi.org/10.1111/exd.70240

Vancouver

Ng BD, Whelan C, Alkon N, Kurowski A, Jonak C, Brunner PM. Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions. Experimental Dermatology. 2026. doi:10.1111/exd.70240

BibTeX
@article{Ng2026,
  author = {Ng, Brandon D and Whelan, Conor and Alkon, Natalia and Kurowski, Agata and Jonak, Constanze and Brunner, Patrick M},
  title = {Molecular Markers Distinguishing Early‐Stage Mycosis Fungoides From Atopic Dermatitis Skin Lesions},
  journal = {Experimental Dermatology},
  year = {2026},
  doi = {10.1111/exd.70240}
}
Start for free →